Icariin inhibits hypoxia/reoxygenation‐induced ferroptosis of cardiomyocytes via regulation of the Nrf2/HO‐1 signaling pathway

Myocardial infarction (MI) is caused by the formation of plaques in the arterial walls, leading to a decrease of blood flow to the heart and myocardium injury as a result of hypoxia. Ferroptosis is a crucial event in myocardial injury, and icariin (ICA) exerts protective effects against myocardial i...

Full description

Saved in:
Bibliographic Details
Published inFEBS open bio Vol. 11; no. 11; pp. 2966 - 2976
Main Authors Liu, Xiu‐Juan, Lv, Yan‐Fei, Cui, Wen‐Zhu, Li, Yan, Liu, Yang, Xue, Yi‐Tao, Dong, Feng
Format Journal Article
LanguageEnglish
Published England John Wiley & Sons, Inc 01.11.2021
John Wiley and Sons Inc
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Myocardial infarction (MI) is caused by the formation of plaques in the arterial walls, leading to a decrease of blood flow to the heart and myocardium injury as a result of hypoxia. Ferroptosis is a crucial event in myocardial injury, and icariin (ICA) exerts protective effects against myocardial injury. Here, we investigated the protective mechanism of ICA in hypoxia/reoxygenation (H/R)‐induced ferroptosis of cardiomyocytes. H9C2 cells were subjected to H/R induction. The content of lactate dehydrogenase and the levels of oxidative stress and intracellular ferrous ion Fe2+ were measured. The levels of ferroptosis markers (ACSL4 and GPX4) were detected. H/R‐induced H9C2 cells were cultured with ICA in the presence or absence of ferroptosis inducer (erastin). Znpp (an HO‐1 inhibitor) was added to ICA‐treated H/R cells to verify the role of the Nrf2/HO‐1 pathway. H/R‐induced H9C2 cells showed reduced viability, enhanced oxidative stress and lactate dehydrogenase content, increased levels of Fe2+ and ACSL4, and decreased levels of GPX4. ICA inhibited H/R‐induced ferroptosis and oxidative stress in cardiomyocytes. Erastin treatment reversed the inhibitory effect of ICA on ferroptosis in H/R cells. The expression of Nrf2 and HO‐1 in H/R‐induced H9C2 cells was reduced, whereas ICA treatment reversed this trend. Inhibition of the Nrf2/HO‐1 pathway reversed the protective effect of ICA on H/R‐induced ferroptosis. Collectively, our results suggest that ICA attenuates H/R‐induced ferroptosis of cardiomyocytes by activating the Nrf2/HO‐1 signaling pathway. Hypoxia/reoxygenation can induce ferroptosis in cardiomyocytes. Here, we report that icariin can activate the Nrf2/HO‐1 signaling pathway and inhibit hypoxia/reoxygenation‐induced ferroptosis in cardiomyocytes.
AbstractList Myocardial infarction (MI) is caused by the formation of plaques in the arterial walls, leading to a decrease of blood flow to the heart and myocardium injury as a result of hypoxia. Ferroptosis is a crucial event in myocardial injury, and icariin (ICA) exerts protective effects against myocardial injury. Here, we investigated the protective mechanism of ICA in hypoxia/reoxygenation (H/R)‐induced ferroptosis of cardiomyocytes. H9C2 cells were subjected to H/R induction. The content of lactate dehydrogenase and the levels of oxidative stress and intracellular ferrous ion Fe²⁺ were measured. The levels of ferroptosis markers (ACSL4 and GPX4) were detected. H/R‐induced H9C2 cells were cultured with ICA in the presence or absence of ferroptosis inducer (erastin). Znpp (an HO‐1 inhibitor) was added to ICA‐treated H/R cells to verify the role of the Nrf2/HO‐1 pathway. H/R‐induced H9C2 cells showed reduced viability, enhanced oxidative stress and lactate dehydrogenase content, increased levels of Fe²⁺ and ACSL4, and decreased levels of GPX4. ICA inhibited H/R‐induced ferroptosis and oxidative stress in cardiomyocytes. Erastin treatment reversed the inhibitory effect of ICA on ferroptosis in H/R cells. The expression of Nrf2 and HO‐1 in H/R‐induced H9C2 cells was reduced, whereas ICA treatment reversed this trend. Inhibition of the Nrf2/HO‐1 pathway reversed the protective effect of ICA on H/R‐induced ferroptosis. Collectively, our results suggest that ICA attenuates H/R‐induced ferroptosis of cardiomyocytes by activating the Nrf2/HO‐1 signaling pathway.
Myocardial infarction (MI) is caused by the formation of plaques in the arterial walls, leading to a decrease of blood flow to the heart and myocardium injury as a result of hypoxia. Ferroptosis is a crucial event in myocardial injury, and icariin (ICA) exerts protective effects against myocardial injury. Here, we investigated the protective mechanism of ICA in hypoxia/reoxygenation (H/R)‐induced ferroptosis of cardiomyocytes. H9C2 cells were subjected to H/R induction. The content of lactate dehydrogenase and the levels of oxidative stress and intracellular ferrous ion Fe2+ were measured. The levels of ferroptosis markers (ACSL4 and GPX4) were detected. H/R‐induced H9C2 cells were cultured with ICA in the presence or absence of ferroptosis inducer (erastin). Znpp (an HO‐1 inhibitor) was added to ICA‐treated H/R cells to verify the role of the Nrf2/HO‐1 pathway. H/R‐induced H9C2 cells showed reduced viability, enhanced oxidative stress and lactate dehydrogenase content, increased levels of Fe2+ and ACSL4, and decreased levels of GPX4. ICA inhibited H/R‐induced ferroptosis and oxidative stress in cardiomyocytes. Erastin treatment reversed the inhibitory effect of ICA on ferroptosis in H/R cells. The expression of Nrf2 and HO‐1 in H/R‐induced H9C2 cells was reduced, whereas ICA treatment reversed this trend. Inhibition of the Nrf2/HO‐1 pathway reversed the protective effect of ICA on H/R‐induced ferroptosis. Collectively, our results suggest that ICA attenuates H/R‐induced ferroptosis of cardiomyocytes by activating the Nrf2/HO‐1 signaling pathway.
Myocardial infarction (MI) is caused by the formation of plaques in the arterial walls, leading to a decrease of blood flow to the heart and myocardium injury as a result of hypoxia. Ferroptosis is a crucial event in myocardial injury, and icariin (ICA) exerts protective effects against myocardial injury. Here, we investigated the protective mechanism of ICA in hypoxia/reoxygenation (H/R)‐induced ferroptosis of cardiomyocytes. H9C2 cells were subjected to H/R induction. The content of lactate dehydrogenase and the levels of oxidative stress and intracellular ferrous ion Fe 2+ were measured. The levels of ferroptosis markers (ACSL4 and GPX4) were detected. H/R‐induced H9C2 cells were cultured with ICA in the presence or absence of ferroptosis inducer (erastin). Znpp (an HO‐1 inhibitor) was added to ICA‐treated H/R cells to verify the role of the Nrf2/HO‐1 pathway. H/R‐induced H9C2 cells showed reduced viability, enhanced oxidative stress and lactate dehydrogenase content, increased levels of Fe 2+ and ACSL4, and decreased levels of GPX4. ICA inhibited H/R‐induced ferroptosis and oxidative stress in cardiomyocytes. Erastin treatment reversed the inhibitory effect of ICA on ferroptosis in H/R cells. The expression of Nrf2 and HO‐1 in H/R‐induced H9C2 cells was reduced, whereas ICA treatment reversed this trend. Inhibition of the Nrf2/HO‐1 pathway reversed the protective effect of ICA on H/R‐induced ferroptosis. Collectively, our results suggest that ICA attenuates H/R‐induced ferroptosis of cardiomyocytes by activating the Nrf2/HO‐1 signaling pathway.
Myocardial infarction (MI) is caused by the formation of plaques in the arterial walls, leading to a decrease of blood flow to the heart and myocardium injury as a result of hypoxia. Ferroptosis is a crucial event in myocardial injury, and icariin (ICA) exerts protective effects against myocardial injury. Here, we investigated the protective mechanism of ICA in hypoxia/reoxygenation (H/R)‐induced ferroptosis of cardiomyocytes. H9C2 cells were subjected to H/R induction. The content of lactate dehydrogenase and the levels of oxidative stress and intracellular ferrous ion Fe2+ were measured. The levels of ferroptosis markers (ACSL4 and GPX4) were detected. H/R‐induced H9C2 cells were cultured with ICA in the presence or absence of ferroptosis inducer (erastin). Znpp (an HO‐1 inhibitor) was added to ICA‐treated H/R cells to verify the role of the Nrf2/HO‐1 pathway. H/R‐induced H9C2 cells showed reduced viability, enhanced oxidative stress and lactate dehydrogenase content, increased levels of Fe2+ and ACSL4, and decreased levels of GPX4. ICA inhibited H/R‐induced ferroptosis and oxidative stress in cardiomyocytes. Erastin treatment reversed the inhibitory effect of ICA on ferroptosis in H/R cells. The expression of Nrf2 and HO‐1 in H/R‐induced H9C2 cells was reduced, whereas ICA treatment reversed this trend. Inhibition of the Nrf2/HO‐1 pathway reversed the protective effect of ICA on H/R‐induced ferroptosis. Collectively, our results suggest that ICA attenuates H/R‐induced ferroptosis of cardiomyocytes by activating the Nrf2/HO‐1 signaling pathway. Hypoxia/reoxygenation can induce ferroptosis in cardiomyocytes. Here, we report that icariin can activate the Nrf2/HO‐1 signaling pathway and inhibit hypoxia/reoxygenation‐induced ferroptosis in cardiomyocytes.
Myocardial infarction (MI) is caused by the formation of plaques in the arterial walls, leading to a decrease of blood flow to the heart and myocardium injury as a result of hypoxia. Ferroptosis is a crucial event in myocardial injury, and icariin (ICA) exerts protective effects against myocardial injury. Here, we investigated the protective mechanism of ICA in hypoxia/reoxygenation (H/R)-induced ferroptosis of cardiomyocytes. H9C2 cells were subjected to H/R induction. The content of lactate dehydrogenase and the levels of oxidative stress and intracellular ferrous ion Fe were measured. The levels of ferroptosis markers (ACSL4 and GPX4) were detected. H/R-induced H9C2 cells were cultured with ICA in the presence or absence of ferroptosis inducer (erastin). Znpp (an HO-1 inhibitor) was added to ICA-treated H/R cells to verify the role of the Nrf2/HO-1 pathway. H/R-induced H9C2 cells showed reduced viability, enhanced oxidative stress and lactate dehydrogenase content, increased levels of Fe and ACSL4, and decreased levels of GPX4. ICA inhibited H/R-induced ferroptosis and oxidative stress in cardiomyocytes. Erastin treatment reversed the inhibitory effect of ICA on ferroptosis in H/R cells. The expression of Nrf2 and HO-1 in H/R-induced H9C2 cells was reduced, whereas ICA treatment reversed this trend. Inhibition of the Nrf2/HO-1 pathway reversed the protective effect of ICA on H/R-induced ferroptosis. Collectively, our results suggest that ICA attenuates H/R-induced ferroptosis of cardiomyocytes by activating the Nrf2/HO-1 signaling pathway.
Myocardial infarction (MI) is caused by the formation of plaques in the arterial walls, leading to a decrease of blood flow to the heart and myocardium injury as a result of hypoxia. Ferroptosis is a crucial event in myocardial injury, and icariin (ICA) exerts protective effects against myocardial injury. Here, we investigated the protective mechanism of ICA in hypoxia/reoxygenation (H/R)-induced ferroptosis of cardiomyocytes. H9C2 cells were subjected to H/R induction. The content of lactate dehydrogenase and the levels of oxidative stress and intracellular ferrous ion Fe2+ were measured. The levels of ferroptosis markers (ACSL4 and GPX4) were detected. H/R-induced H9C2 cells were cultured with ICA in the presence or absence of ferroptosis inducer (erastin). Znpp (an HO-1 inhibitor) was added to ICA-treated H/R cells to verify the role of the Nrf2/HO-1 pathway. H/R-induced H9C2 cells showed reduced viability, enhanced oxidative stress and lactate dehydrogenase content, increased levels of Fe2+ and ACSL4, and decreased levels of GPX4. ICA inhibited H/R-induced ferroptosis and oxidative stress in cardiomyocytes. Erastin treatment reversed the inhibitory effect of ICA on ferroptosis in H/R cells. The expression of Nrf2 and HO-1 in H/R-induced H9C2 cells was reduced, whereas ICA treatment reversed this trend. Inhibition of the Nrf2/HO-1 pathway reversed the protective effect of ICA on H/R-induced ferroptosis. Collectively, our results suggest that ICA attenuates H/R-induced ferroptosis of cardiomyocytes by activating the Nrf2/HO-1 signaling pathway.Myocardial infarction (MI) is caused by the formation of plaques in the arterial walls, leading to a decrease of blood flow to the heart and myocardium injury as a result of hypoxia. Ferroptosis is a crucial event in myocardial injury, and icariin (ICA) exerts protective effects against myocardial injury. Here, we investigated the protective mechanism of ICA in hypoxia/reoxygenation (H/R)-induced ferroptosis of cardiomyocytes. H9C2 cells were subjected to H/R induction. The content of lactate dehydrogenase and the levels of oxidative stress and intracellular ferrous ion Fe2+ were measured. The levels of ferroptosis markers (ACSL4 and GPX4) were detected. H/R-induced H9C2 cells were cultured with ICA in the presence or absence of ferroptosis inducer (erastin). Znpp (an HO-1 inhibitor) was added to ICA-treated H/R cells to verify the role of the Nrf2/HO-1 pathway. H/R-induced H9C2 cells showed reduced viability, enhanced oxidative stress and lactate dehydrogenase content, increased levels of Fe2+ and ACSL4, and decreased levels of GPX4. ICA inhibited H/R-induced ferroptosis and oxidative stress in cardiomyocytes. Erastin treatment reversed the inhibitory effect of ICA on ferroptosis in H/R cells. The expression of Nrf2 and HO-1 in H/R-induced H9C2 cells was reduced, whereas ICA treatment reversed this trend. Inhibition of the Nrf2/HO-1 pathway reversed the protective effect of ICA on H/R-induced ferroptosis. Collectively, our results suggest that ICA attenuates H/R-induced ferroptosis of cardiomyocytes by activating the Nrf2/HO-1 signaling pathway.
Myocardial infarction (MI) is caused by the formation of plaques in the arterial walls, leading to a decrease of blood flow to the heart and myocardium injury as a result of hypoxia. Ferroptosis is a crucial event in myocardial injury, and icariin (ICA) exerts protective effects against myocardial injury. Here, we investigated the protective mechanism of ICA in hypoxia/reoxygenation (H/R)‐induced ferroptosis of cardiomyocytes. H9C2 cells were subjected to H/R induction. The content of lactate dehydrogenase and the levels of oxidative stress and intracellular ferrous ion Fe 2+ were measured. The levels of ferroptosis markers (ACSL4 and GPX4) were detected. H/R‐induced H9C2 cells were cultured with ICA in the presence or absence of ferroptosis inducer (erastin). Znpp (an HO‐1 inhibitor) was added to ICA‐treated H/R cells to verify the role of the Nrf2/HO‐1 pathway. H/R‐induced H9C2 cells showed reduced viability, enhanced oxidative stress and lactate dehydrogenase content, increased levels of Fe 2+ and ACSL4, and decreased levels of GPX4. ICA inhibited H/R‐induced ferroptosis and oxidative stress in cardiomyocytes. Erastin treatment reversed the inhibitory effect of ICA on ferroptosis in H/R cells. The expression of Nrf2 and HO‐1 in H/R‐induced H9C2 cells was reduced, whereas ICA treatment reversed this trend. Inhibition of the Nrf2/HO‐1 pathway reversed the protective effect of ICA on H/R‐induced ferroptosis. Collectively, our results suggest that ICA attenuates H/R‐induced ferroptosis of cardiomyocytes by activating the Nrf2/HO‐1 signaling pathway. Hypoxia/reoxygenation can induce ferroptosis in cardiomyocytes. Here, we report that icariin can activate the Nrf2/HO‐1 signaling pathway and inhibit hypoxia/reoxygenation‐induced ferroptosis in cardiomyocytes.
Author Liu, Xiu‐Juan
Li, Yan
Lv, Yan‐Fei
Cui, Wen‐Zhu
Liu, Yang
Xue, Yi‐Tao
Dong, Feng
AuthorAffiliation 3 Department of cardiovascular diseases The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine Jinan China
1 Department of cardiovascular diseases Shandong University of Traditional Chinese Medicine Affiliated Hospital Jinan China
2 Department of Rehabilitation Medicine Shandong Provincial Hospital affiliated to Shandong First Medical University Jinan China
AuthorAffiliation_xml – name: 3 Department of cardiovascular diseases The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine Jinan China
– name: 1 Department of cardiovascular diseases Shandong University of Traditional Chinese Medicine Affiliated Hospital Jinan China
– name: 2 Department of Rehabilitation Medicine Shandong Provincial Hospital affiliated to Shandong First Medical University Jinan China
Author_xml – sequence: 1
  givenname: Xiu‐Juan
  surname: Liu
  fullname: Liu, Xiu‐Juan
  organization: Shandong University of Traditional Chinese Medicine Affiliated Hospital
– sequence: 2
  givenname: Yan‐Fei
  surname: Lv
  fullname: Lv, Yan‐Fei
  organization: Shandong Provincial Hospital affiliated to Shandong First Medical University
– sequence: 3
  givenname: Wen‐Zhu
  surname: Cui
  fullname: Cui, Wen‐Zhu
  organization: The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine
– sequence: 4
  givenname: Yan
  surname: Li
  fullname: Li, Yan
  organization: Shandong University of Traditional Chinese Medicine Affiliated Hospital
– sequence: 5
  givenname: Yang
  surname: Liu
  fullname: Liu, Yang
  organization: Shandong University of Traditional Chinese Medicine Affiliated Hospital
– sequence: 6
  givenname: Yi‐Tao
  surname: Xue
  fullname: Xue, Yi‐Tao
  organization: Shandong University of Traditional Chinese Medicine Affiliated Hospital
– sequence: 7
  givenname: Feng
  orcidid: 0000-0002-2099-8467
  surname: Dong
  fullname: Dong, Feng
  email: dongfengg0103@163.com
  organization: Shandong University of Traditional Chinese Medicine Affiliated Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34407320$$D View this record in MEDLINE/PubMed
BookMark eNqFkr1u2zAUhYUiRfPTzN0KAV26OOafKHEp0ARJYyBolnYmKOpSpiGTLikl0Vb0CfqMeZLSdmokGRIuJC7P-chLnsNsz3kHWfYBoxOMEJkSgvGkYJyeYEpK_iY72FX2Hq33s-MYFygNjjBH6F22TxlDJSXoIPsz0ypY63Lr5ra2fczn48rfWTUN4O_GFpzqrXf3v_9a1wwamtxACH7V-2hj7k2e7I31y9HrsYeY31iVB2iHbmNbC_o55N-DIdPL60TBebStU511bb5S_fxWje-zt0Z1EY4f5qPs58X5j7PLydX1t9nZ16uJLkTBJ3VZioppXtVamMKIGmqNjaEMtNGNFsgwVlBWAldYCUwqRaFWTQ2oEVw3hh5lsy238WohV8EuVRilV1ZuCj60UoXe6g5kqROJsRrREjHKUW0QrgSFsgBSgmgS68uWtRrqJTQaXB9U9wT6dMfZuWz9jawKziijCfD5ARD8rwFiL5c2aug65cAPUZISV5RiQfDr0oKTihIuUJJ-eiZd-CGk544y_TYtGBVMvKQihcCCUlatb_jxcYu73v5nJwmmW4EOPsYAZifBSK4DKtcRlOsIyk1Ak6N45tC23wQlvZHtXvDxre_WdjC-doy8OD9lW-M_Tc_6uA
CitedBy_id crossref_primary_10_1016_j_lfs_2023_122007
crossref_primary_10_3389_fphar_2022_906073
crossref_primary_10_1016_j_biopha_2023_115432
crossref_primary_10_1016_j_phrs_2024_107281
crossref_primary_10_1371_journal_pone_0302650
crossref_primary_10_31083_j_rcm2505149
crossref_primary_10_2174_0929867330666230223103524
crossref_primary_10_1007_s10495_023_01814_8
crossref_primary_10_1016_j_cellsig_2024_111328
crossref_primary_10_1016_j_tice_2022_101956
crossref_primary_10_1016_j_prmcm_2024_100377
crossref_primary_10_1007_s11033_023_08948_7
crossref_primary_10_4103_apjtb_apjtb_588_23
crossref_primary_10_1186_s12906_024_04463_9
crossref_primary_10_1007_s00011_023_01842_9
crossref_primary_10_12677_acm_2024_1451731
crossref_primary_10_1007_s00210_022_02243_1
crossref_primary_10_1080_1061186X_2022_2085728
crossref_primary_10_1016_j_lfs_2024_122439
crossref_primary_10_3389_fphar_2023_1146651
crossref_primary_10_3390_molecules29092005
crossref_primary_10_1016_j_ejphar_2023_175985
crossref_primary_10_1038_s41416_023_02149_6
crossref_primary_10_1155_2022_3961495
crossref_primary_10_3389_fendo_2024_1366285
crossref_primary_10_3390_antiox13030334
crossref_primary_10_3389_fncel_2024_1475934
crossref_primary_10_3389_fphar_2022_956355
crossref_primary_10_3892_ijmm_2024_5402
crossref_primary_10_3389_fphar_2022_933732
crossref_primary_10_1080_08916934_2023_2290357
crossref_primary_10_3390_ijms241512510
crossref_primary_10_3390_ijms25020897
crossref_primary_10_3389_fpls_2023_1133062
crossref_primary_10_3390_molecules28237929
crossref_primary_10_1007_s13105_023_00945_5
crossref_primary_10_1007_s10557_024_07664_z
crossref_primary_10_1155_2022_4918343
crossref_primary_10_1038_s41413_024_00398_6
crossref_primary_10_3389_fphar_2024_1476718
crossref_primary_10_3390_medicina59030420
crossref_primary_10_3892_or_2024_8851
crossref_primary_10_1016_j_phytochem_2023_113841
crossref_primary_10_3389_fphar_2023_1103971
crossref_primary_10_3390_agriculture13122192
crossref_primary_10_1016_j_fct_2024_114926
crossref_primary_10_1016_j_placenta_2024_10_013
crossref_primary_10_1371_journal_pone_0317295
crossref_primary_10_1016_j_tem_2023_10_010
crossref_primary_10_1186_s13018_024_05183_z
crossref_primary_10_1016_j_cellsig_2024_111345
crossref_primary_10_1186_s12872_024_04220_3
crossref_primary_10_7717_peerj_14952
crossref_primary_10_3390_cells12071050
crossref_primary_10_3892_etm_2024_12519
crossref_primary_10_1016_j_jep_2024_117941
crossref_primary_10_1016_j_jphotobiol_2024_112991
crossref_primary_10_1002_cbin_11763
crossref_primary_10_1016_j_freeradbiomed_2024_05_012
crossref_primary_10_1080_13880209_2023_2244004
crossref_primary_10_3389_fphar_2022_977062
crossref_primary_10_1007_s00210_022_02262_y
crossref_primary_10_3389_fphar_2023_1286718
crossref_primary_10_1002_ptr_8278
crossref_primary_10_3390_antiox11010150
crossref_primary_10_32604_biocell_2022_018530
crossref_primary_10_1016_j_biopha_2023_114706
crossref_primary_10_1111_jcmm_18209
crossref_primary_10_3233_CH_242444
crossref_primary_10_3390_antiox11030583
crossref_primary_10_1002_med_21933
crossref_primary_10_1007_s10571_023_01388_8
crossref_primary_10_1038_s41598_024_67557_x
crossref_primary_10_2174_0929867330666221111162905
Cites_doi 10.1007/s11325-020-02091-4
10.1016/j.intimp.2019.05.033
10.1155/2018/3071959
10.21037/apm.2019.11.25
10.1016/j.freeradbiomed.2009.07.035
10.1038/cdd.2015.158
10.1016/j.biopha.2019.109567
10.1016/j.biopha.2017.01.147
10.1016/j.ab.2016.10.021
10.1016/bs.apha.2019.10.004
10.1089/ars.2016.6940
10.1172/JCI62874
10.1016/j.tips.2017.02.005
10.1111/1755-5922.12121
10.13075/mp.5893.00137
10.1016/j.fct.2013.12.006
10.1016/j.biopha.2016.08.016
10.1006/meth.2001.1262
10.24272/j.issn.2095-8137.2020.042
10.1007/s12013-014-0506-3
10.1016/j.lfs.2018.08.059
10.3892/mmr.2020.11114
10.1111/jpi.12503
10.3389/fcell.2020.00559
10.1016/j.cell.2013.12.010
10.3390/ijms140917845
10.3892/etm.2020.9504
10.1016/j.bbrc.2018.03.113
10.1073/pnas.1821022116
10.1016/j.ijbiomac.2018.11.190
10.1161/ATVBAHA.118.311832
10.1155/2017/9743280
10.3892/etm.2014.1598
10.1038/s41586-019-1426-6
10.1016/j.cell.2012.03.042
10.1007/s12013-015-0553-4
10.1007/s12013-015-0669-6
10.1007/s10565-020-09530-8
10.1016/j.redox.2020.101670
10.1146/annurev-pharmtox-011112-140320
10.1155/2017/7018393
10.1089/dna.2019.5097
10.1016/j.bbagen.2017.05.019
10.1016/j.ejphar.2018.08.024
10.1016/j.redox.2019.101107
10.1016/j.tcb.2015.10.014
10.1186/s12974-019-1472-x
10.1038/s41418-019-0299-4
10.3892/mmr.2015.3289
10.1016/j.jacc.2015.02.032
10.1016/j.ahj.2015.08.005
ContentType Journal Article
Copyright 2021 The Authors. published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies
2021 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.
2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2021 The Authors. published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies
– notice: 2021 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.
– notice: 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
8FE
8FH
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
GNUQQ
HCIFZ
LK8
M7P
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
7S9
L.6
5PM
DOA
DOI 10.1002/2211-5463.13276
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
ProQuest Central Student
SciTech Premium Collection
Biological Sciences
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Biological Science Collection
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
Biological Science Database
ProQuest SciTech Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Academic UKI Edition
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList AGRICOLA

Publicly Available Content Database
CrossRef

MEDLINE
Publicly Available Content Database
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 24P
  name: Wiley Online Library Open Access (Activated by CARLI)
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate ICA inhibits ferroptosis
EISSN 2211-5463
EndPage 2976
ExternalDocumentID oai_doaj_org_article_7c53444b03704360bf01893e75e27e9d
PMC8564343
1010022211546313276
34407320
10_1002_2211_5463_13276
FEB413276
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United States--US
China
Germany
GeographicLocations_xml – name: China
– name: United States--US
– name: Germany
GrantInformation_xml – fundername: Study on the mechanism of improving exercise tolerance of heart failure by Yi Qi WenYang herbal medicine based on mitochondrial dynamics
  funderid: 81774247
– fundername: Study on the mechanism of improving exercise tolerance of heart failure by Yi Qi WenYang herbal medicine based on mitochondrial dynamics
  grantid: 81774247
GroupedDBID ---
--K
0R~
0SF
1OC
24P
4.4
53G
5VS
8FE
8FH
AACTN
AAEDT
AAEDW
AAFTH
AAFWJ
AAHBH
AAHHS
AAIKJ
AALRI
AAXUO
AAZKR
ABMAC
ACCFJ
ACCMX
ACXQS
ADBBV
ADEZE
ADKYN
ADPDF
ADRAZ
ADVLN
ADZMN
ADZOD
AEEZP
AENEX
AEQDE
AEXQZ
AFKRA
AGHFR
AITUG
AIWBW
AJBDE
AKRWK
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMRAJ
AOIJS
AVUZU
BBNVY
BCNDV
BENPR
BHPHI
CCPQU
DIK
EBS
EJD
EMOBN
FDB
GROUPED_DOAJ
HCIFZ
HYE
HZ~
IAO
IGS
IHR
INH
IPNFZ
ITC
IXB
KQ8
LK8
M41
M48
M7P
M~E
NCXOZ
O-L
O9-
OK1
OVD
OVEED
PIMPY
PROAC
R9-
RIG
ROL
RPM
SSZ
TEORI
WIN
XH2
AAYWO
AAYXX
ACVFH
ADCNI
AEUPX
AFPKN
AFPUW
AIGII
AKBMS
AKYEP
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
AAMMB
ABUWG
AEFGJ
AGXDD
AIDQK
AIDYY
AZQEC
DWQXO
GNUQQ
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
7S9
L.6
5PM
PUEGO
ID FETCH-LOGICAL-c5956-b77984c68bc9f5f9bebc1ff34ecfcdc90f445347e6a1a9128a3ebadbe0d96cdf3
IEDL.DBID BENPR
ISSN 2211-5463
IngestDate Wed Aug 27 01:30:58 EDT 2025
Thu Aug 21 18:12:19 EDT 2025
Fri Jul 11 18:36:29 EDT 2025
Fri Jul 11 06:09:58 EDT 2025
Wed Aug 13 11:29:55 EDT 2025
Wed Aug 13 04:59:00 EDT 2025
Wed Feb 19 02:25:57 EST 2025
Tue Jul 01 04:41:45 EDT 2025
Thu Apr 24 23:08:07 EDT 2025
Wed Jan 22 16:28:21 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords cardiomyocytes
icariin
Nrf2/HO-1 pathway
ferroptosis
oxidative stress
hypoxia/reoxygenation
Language English
License Attribution
2021 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5956-b77984c68bc9f5f9bebc1ff34ecfcdc90f445347e6a1a9128a3ebadbe0d96cdf3
Notes Xiu‐Juan Liu and Yan‐Fei Lv contributed equally to this article
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-2099-8467
OpenAccessLink https://www.proquest.com/docview/3203543949?pq-origsite=%requestingapplication%
PMID 34407320
PQID 2591933483
PQPubID 4368360
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_7c53444b03704360bf01893e75e27e9d
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8564343
proquest_miscellaneous_2718331921
proquest_miscellaneous_2562832690
proquest_journals_3203543949
proquest_journals_2591933483
pubmed_primary_34407320
crossref_primary_10_1002_2211_5463_13276
crossref_citationtrail_10_1002_2211_5463_13276
wiley_primary_10_1002_2211_5463_13276_FEB413276
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate November 2021
PublicationDateYYYYMMDD 2021-11-01
PublicationDate_xml – month: 11
  year: 2021
  text: November 2021
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Amsterdam
– name: Hoboken
PublicationTitle FEBS open bio
PublicationTitleAlternate FEBS Open Bio
PublicationYear 2021
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
– name: Wiley
References 2009; 47
2021; 21
2015; 73
2015; 72
2017; 88
2015; 33
2017; 1861
2013; 123
2019; 16
2019; 125
2018; 41
2019; 120
2014; 64
2020; 8
2021; 37
2015; 170
2013; 14
2017; 38
2019; 23
2013; 53
2019; 26
2018; 499
2018; 213
2019; 116
2016; 83
2020; 87
2014; 7
2018; 38
2017; 524
2019; 8
2019; 73
2017; 2017
2017; 26
2020; 41
2015; 11
2020; 39
2020; 36
2018; 65
2012; 149
2001; 25
2014; 156
2018; 17
2018; 2018
2015; 66
2015; 65
2020; 24
2018; 838
2020; 22
2016; 26
2016; 23
2019; 572
e_1_2_10_23_1
e_1_2_10_46_1
e_1_2_10_21_1
e_1_2_10_44_1
e_1_2_10_42_1
Ren ZH (e_1_2_10_31_1) 2018; 17
e_1_2_10_40_1
e_1_2_10_2_1
e_1_2_10_4_1
e_1_2_10_18_1
e_1_2_10_53_1
e_1_2_10_6_1
e_1_2_10_16_1
e_1_2_10_39_1
e_1_2_10_8_1
e_1_2_10_14_1
e_1_2_10_37_1
e_1_2_10_13_1
e_1_2_10_34_1
e_1_2_10_11_1
e_1_2_10_32_1
e_1_2_10_30_1
e_1_2_10_51_1
e_1_2_10_29_1
e_1_2_10_27_1
e_1_2_10_25_1
e_1_2_10_48_1
e_1_2_10_24_1
e_1_2_10_45_1
e_1_2_10_22_1
e_1_2_10_43_1
e_1_2_10_20_1
e_1_2_10_41_1
e_1_2_10_52_1
e_1_2_10_3_1
e_1_2_10_19_1
e_1_2_10_54_1
e_1_2_10_5_1
e_1_2_10_17_1
e_1_2_10_38_1
e_1_2_10_7_1
e_1_2_10_15_1
e_1_2_10_36_1
e_1_2_10_12_1
e_1_2_10_35_1
e_1_2_10_9_1
e_1_2_10_10_1
e_1_2_10_33_1
Li L (e_1_2_10_26_1) 2018; 41
e_1_2_10_50_1
e_1_2_10_28_1
e_1_2_10_49_1
e_1_2_10_47_1
References_xml – volume: 65
  year: 2018
  article-title: Inhibitory effect of melatonin on necroptosis via repressing the Ripk3‐PGAM5‐CypD‐mPTP pathway attenuates cardiac microvascular ischemia‐reperfusion injury
  publication-title: J Pineal Res
– volume: 524
  start-page: 13
  year: 2017
  end-page: 30
  article-title: Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: analytical and biological challenges
  publication-title: Anal Biochem
– volume: 26
  start-page: 660
  year: 2017
  end-page: 675
  article-title: Lymphocyte communication in myocardial ischemia/reperfusion injury
  publication-title: Antioxid Redox Signal
– volume: 83
  start-page: 1089
  year: 2016
  end-page: 1094
  article-title: Icariin attenuated oxidative stress induced‐cardiac apoptosis by mitochondria protection and ERK activation
  publication-title: Biomed Pharmacother
– volume: 39
  start-page: 210
  year: 2020
  end-page: 225
  article-title: Ferroptosis is involved in diabetes myocardial ischemia/reperfusion injury through endoplasmic reticulum stress
  publication-title: DNA Cell Biol
– volume: 7
  start-page: 1116
  year: 2014
  end-page: 1122
  article-title: Icariin attenuates angiotensin II‐induced hypertrophy and apoptosis in H9c2 cardiomyocytes by inhibiting reactive oxygen species‐dependent JNK and p38 pathways
  publication-title: Exp Ther Med
– volume: 120
  year: 2019
  article-title: Icariin modulates carrageenan‐induced acute inflammation through HO‐1/Nrf2 and NF‐kB signaling pathways
  publication-title: Biomed Pharmacother
– volume: 22
  start-page: 175
  year: 2020
  end-page: 184
  article-title: Dexmedetomidine alleviated sepsis‐induced myocardial ferroptosis and septic heart injury
  publication-title: Mol Med Rep
– volume: 37
  start-page: 51
  year: 2021
  end-page: 64
  article-title: Human umbilical cord blood‐derived MSCs exosome attenuate myocardial injury by inhibiting ferroptosis in acute myocardial infarction mice
  publication-title: Cell Biol Toxicol
– volume: 16
  start-page: 92
  year: 2019
  article-title: Icariin attenuates neuroinflammation and exerts dopamine neuroprotection via an Nrf2‐dependent manner
  publication-title: J Neuroinflammation
– volume: 41
  start-page: 220
  year: 2020
  end-page: 230
  article-title: The pathological role of ferroptosis in ischemia/reperfusion‐related injury
  publication-title: Zool Res
– volume: 125
  start-page: 496
  year: 2019
  end-page: 502
  article-title: Involvement of Nrf2 in myocardial ischemia and reperfusion injury
  publication-title: Int J Biol Macromol
– volume: 149
  start-page: 1060
  year: 2012
  end-page: 1072
  article-title: Ferroptosis: an iron‐dependent form of nonapoptotic cell death
  publication-title: Cell
– volume: 499
  start-page: 44
  year: 2018
  end-page: 51
  article-title: ENPP2 protects cardiomyocytes from erastin‐induced ferroptosis
  publication-title: Biochem Biophys Res Commun
– volume: 1861
  start-page: 1893
  year: 2017
  end-page: 1900
  article-title: Ferroptosis: role of lipid peroxidation, iron and ferritinophagy
  publication-title: Biochim Biophys Acta Gen Subj
– volume: 26
  start-page: 2284
  year: 2019
  end-page: 2299
  article-title: Ischemia‐induced ACSL4 activation contributes to ferroptosis‐mediated tissue injury in intestinal ischemia/reperfusion
  publication-title: Cell Death Differ
– volume: 26
  start-page: 165
  year: 2016
  end-page: 176
  article-title: Ferroptosis: death by lipid peroxidation
  publication-title: Trends Cell Biol
– volume: 123
  start-page: 92
  year: 2013
  end-page: 100
  article-title: Myocardial ischemia‐reperfusion injury: a neglected therapeutic target
  publication-title: J Clin Invest
– volume: 73
  start-page: 229
  year: 2015
  end-page: 235
  article-title: Icariin exerts protective effect against myocardial ischemia/reperfusion injury in rats
  publication-title: Cell Biochem Biophys
– volume: 156
  start-page: 317
  year: 2014
  end-page: 331
  article-title: Regulation of ferroptotic cancer cell death by GPX4
  publication-title: Cell
– volume: 8
  start-page: 565
  year: 2019
  end-page: 575
  article-title: Resveratrol increase myocardial Nrf2 expression in type 2 diabetic rats and alleviate myocardial ischemia/reperfusion injury (MIRI)
  publication-title: Ann Palliat Med
– volume: 14
  start-page: 17845
  year: 2013
  end-page: 17860
  article-title: Icariin protects rat cardiac H9c2 cells from apoptosis by inhibiting endoplasmic reticulum stress
  publication-title: Int J Mol Sci
– volume: 23
  start-page: 369
  year: 2016
  end-page: 379
  article-title: Ferroptosis: process and function
  publication-title: Cell Death Differ
– volume: 8
  start-page: 559
  year: 2020
  article-title: Icariin prevents extracellular matrix accumulation and ameliorates experimental diabetic kidney disease by inhibiting oxidative stress via GPER mediated p62‐dependent Keap1 degradation and Nrf2 activation
  publication-title: Front Cell Dev Biol
– volume: 2018
  start-page: 3071959
  year: 2018
  article-title: Effects of dexmedetomidine postconditioning on myocardial ischemia/reperfusion injury in diabetic rats: role of the PI3K/Akt‐dependent signaling pathway
  publication-title: J Diabetes Res
– volume: 73
  start-page: 304
  year: 2019
  end-page: 311
  article-title: Icariin targets Nrf2 signaling to inhibit microglia‐mediated neuroinflammation
  publication-title: Int Immunopharmacol
– volume: 25
  start-page: 402
  year: 2001
  end-page: 408
  article-title: Analysis of relative gene expression data using real‐time quantitative PCR and the 2(‐Delta Delta C(T)) Method
  publication-title: Methods
– volume: 65
  start-page: 1454
  year: 2015
  end-page: 1471
  article-title: Evolving therapies for myocardial ischemia/reperfusion injury
  publication-title: J Am Coll Cardiol
– volume: 36
  year: 2020
  article-title: Hypoxia inhibits ferritinophagy, increases mitochondrial ferritin, and protects from ferroptosis
  publication-title: Redox Biol
– volume: 170
  start-page: 971
  year: 2015
  end-page: 980
  article-title: Reperfusion therapy for acute myocardial infarction: concepts and controversies from inception to acceptance
  publication-title: Am Heart J
– volume: 38
  start-page: 489
  year: 2017
  end-page: 498
  article-title: Ferroptosis inhibition: mechanisms and opportunities
  publication-title: Trends Pharmacol Sci
– volume: 33
  start-page: 134
  year: 2015
  end-page: 140
  article-title: The cardioprotective effect of icariin on ischemia‐reperfusion injury in isolated rat heart: potential involvement of the PI3K‐Akt signaling pathway
  publication-title: Cardiovasc Ther
– volume: 87
  start-page: 179
  year: 2020
  end-page: 203
  article-title: Pharmacological effects of icariin
  publication-title: Adv Pharmacol
– volume: 72
  start-page: 589
  year: 2015
  end-page: 597
  article-title: Icariin acts as a potential agent for preventing cardiac ischemia/reperfusion injury
  publication-title: Cell Biochem Biophys
– volume: 88
  start-page: 823
  year: 2017
  end-page: 831
  article-title: Icariin prevents hypertension‐induced cardiomyocyte apoptosis through the mitochondrial apoptotic pathway
  publication-title: Biomed Pharmacother
– volume: 2017
  year: 2017
  article-title: NLRP3 inflammasome activation‐mediated pyroptosis aggravates myocardial ischemia/reperfusion injury in diabetic rats
  publication-title: Oxid Med Cell Longev
– volume: 838
  start-page: 53
  year: 2018
  end-page: 59
  article-title: Betulinic acid alleviates myocardial hypoxia/reoxygenation injury via inducing Nrf2/HO‐1 and inhibiting p38 and JNK pathways
  publication-title: Eur J Pharmacol
– volume: 47
  start-page: 1304
  year: 2009
  end-page: 1309
  article-title: Nrf 2:INrf2 (Keap1) signaling in oxidative stress
  publication-title: Free Radic Biol Med
– volume: 24
  start-page: 1767
  year: 2020
  end-page: 1773
  article-title: The role of ferroptosis in chronic intermittent hypoxia‐induced liver injury in rats
  publication-title: Sleep Breath
– volume: 572
  start-page: 402
  year: 2019
  end-page: 406
  article-title: Intercellular interaction dictates cancer cell ferroptosis via NF2‐YAP signalling
  publication-title: Nature
– volume: 72
  start-page: 865
  year: 2015
  end-page: 867
  article-title: Myocardial infarction: symptoms and treatments
  publication-title: Cell Biochem Biophys
– volume: 116
  start-page: 2672
  year: 2019
  end-page: 2680
  article-title: Ferroptosis as a target for protection against cardiomyopathy
  publication-title: Proc Natl Acad Sci USA
– volume: 17
  start-page: 3336
  year: 2018
  end-page: 3343
  article-title: Icariin protects against ischemia‐reperfusion injury in H9C2 cells by upregulating heat shock protein 20
  publication-title: Mol Med Rep
– volume: 213
  start-page: 25
  year: 2018
  end-page: 31
  article-title: Relaxin protects cardiomyocytes against hypoxia‐induced damage in in‐vitro conditions: Involvement of Nrf2/HO‐1 signaling pathway
  publication-title: Life Sci
– volume: 53
  start-page: 401
  year: 2013
  end-page: 426
  article-title: Role of nrf2 in oxidative stress and toxicity
  publication-title: Annu Rev Pharmacol Toxicol
– volume: 21
  start-page: 72
  year: 2021
  article-title: Icariin enhances cell survival in lipopolysaccharide‐induced synoviocytes by suppressing ferroptosis via the Xc‐/GPX4 axis
  publication-title: Exp Ther Med
– volume: 64
  start-page: 307
  year: 2014
  end-page: 313
  article-title: Icaritin attenuates cigarette smoke‐mediated oxidative stress in human lung epithelial cells via activation of PI3K‐AKT and Nrf2 signaling
  publication-title: Food Chem Toxicol
– volume: 38
  start-page: 2755
  year: 2018
  end-page: 2762
  article-title: Intravenous heme arginate induces HO‐1 (heme oxygenase‐1) in the human heart
  publication-title: Arterioscler Thromb Vasc Biol
– volume: 41
  start-page: 3051
  year: 2018
  end-page: 3062
  article-title: Ferroptosis is associated with oxygen‐glucose deprivation/reoxygenation‐induced Sertoli cell death
  publication-title: Int J Mol Med
– volume: 2017
  year: 2017
  article-title: Ischemia/reperfusion injury following acute myocardial infarction: a critical issue for clinicians and forensic pathologists
  publication-title: Mediators Inflamm
– volume: 11
  start-page: 4327
  year: 2015
  end-page: 4332
  article-title: Icariin protects H9c2 cardiomyocytes from lipopolysaccharide‐induced injury via inhibition of the reactive oxygen species‐dependent c‐Jun N‐terminal kinases/nuclear factor‐kappaB pathway
  publication-title: Mol Med Rep
– volume: 23
  year: 2019
  article-title: NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis
  publication-title: Redox Biol
– volume: 66
  start-page: 393
  year: 2015
  end-page: 405
  article-title: Today's oxidative stress markers
  publication-title: Med Pr
– ident: e_1_2_10_28_1
  doi: 10.1007/s11325-020-02091-4
– ident: e_1_2_10_33_1
  doi: 10.1016/j.intimp.2019.05.033
– ident: e_1_2_10_37_1
  doi: 10.1155/2018/3071959
– ident: e_1_2_10_50_1
  doi: 10.21037/apm.2019.11.25
– ident: e_1_2_10_35_1
  doi: 10.1016/j.freeradbiomed.2009.07.035
– ident: e_1_2_10_11_1
  doi: 10.1038/cdd.2015.158
– ident: e_1_2_10_46_1
  doi: 10.1016/j.biopha.2019.109567
– ident: e_1_2_10_32_1
  doi: 10.1016/j.biopha.2017.01.147
– ident: e_1_2_10_42_1
  doi: 10.1016/j.ab.2016.10.021
– ident: e_1_2_10_44_1
  doi: 10.1016/bs.apha.2019.10.004
– ident: e_1_2_10_36_1
  doi: 10.1089/ars.2016.6940
– ident: e_1_2_10_3_1
  doi: 10.1172/JCI62874
– ident: e_1_2_10_12_1
  doi: 10.1016/j.tips.2017.02.005
– ident: e_1_2_10_19_1
  doi: 10.1111/1755-5922.12121
– ident: e_1_2_10_43_1
  doi: 10.13075/mp.5893.00137
– ident: e_1_2_10_48_1
  doi: 10.1016/j.fct.2013.12.006
– ident: e_1_2_10_30_1
  doi: 10.1016/j.biopha.2016.08.016
– ident: e_1_2_10_23_1
  doi: 10.1006/meth.2001.1262
– ident: e_1_2_10_13_1
  doi: 10.24272/j.issn.2095-8137.2020.042
– ident: e_1_2_10_18_1
  doi: 10.1007/s12013-014-0506-3
– ident: e_1_2_10_29_1
  doi: 10.1016/j.lfs.2018.08.059
– ident: e_1_2_10_52_1
  doi: 10.3892/mmr.2020.11114
– ident: e_1_2_10_7_1
  doi: 10.1111/jpi.12503
– volume: 41
  start-page: 3051
  year: 2018
  ident: e_1_2_10_26_1
  article-title: Ferroptosis is associated with oxygen‐glucose deprivation/reoxygenation‐induced Sertoli cell death
  publication-title: Int J Mol Med
– ident: e_1_2_10_54_1
  doi: 10.3389/fcell.2020.00559
– ident: e_1_2_10_39_1
  doi: 10.1016/j.cell.2013.12.010
– ident: e_1_2_10_16_1
  doi: 10.3390/ijms140917845
– ident: e_1_2_10_45_1
  doi: 10.3892/etm.2020.9504
– ident: e_1_2_10_22_1
  doi: 10.1016/j.bbrc.2018.03.113
– ident: e_1_2_10_14_1
  doi: 10.1073/pnas.1821022116
– ident: e_1_2_10_49_1
  doi: 10.1016/j.ijbiomac.2018.11.190
– ident: e_1_2_10_53_1
  doi: 10.1161/ATVBAHA.118.311832
– ident: e_1_2_10_8_1
  doi: 10.1155/2017/9743280
– ident: e_1_2_10_21_1
  doi: 10.3892/etm.2014.1598
– ident: e_1_2_10_38_1
  doi: 10.1038/s41586-019-1426-6
– ident: e_1_2_10_10_1
  doi: 10.1016/j.cell.2012.03.042
– ident: e_1_2_10_2_1
  doi: 10.1007/s12013-015-0553-4
– ident: e_1_2_10_15_1
  doi: 10.1007/s12013-015-0669-6
– ident: e_1_2_10_25_1
  doi: 10.1007/s10565-020-09530-8
– ident: e_1_2_10_27_1
  doi: 10.1016/j.redox.2020.101670
– ident: e_1_2_10_34_1
  doi: 10.1146/annurev-pharmtox-011112-140320
– ident: e_1_2_10_6_1
  doi: 10.1155/2017/7018393
– ident: e_1_2_10_9_1
  doi: 10.1089/dna.2019.5097
– ident: e_1_2_10_24_1
  doi: 10.1016/j.bbagen.2017.05.019
– ident: e_1_2_10_20_1
  doi: 10.1016/j.ejphar.2018.08.024
– ident: e_1_2_10_51_1
  doi: 10.1016/j.redox.2019.101107
– ident: e_1_2_10_41_1
  doi: 10.1016/j.tcb.2015.10.014
– ident: e_1_2_10_47_1
  doi: 10.1186/s12974-019-1472-x
– ident: e_1_2_10_40_1
  doi: 10.1038/s41418-019-0299-4
– ident: e_1_2_10_17_1
  doi: 10.3892/mmr.2015.3289
– volume: 17
  start-page: 3336
  year: 2018
  ident: e_1_2_10_31_1
  article-title: Icariin protects against ischemia‐reperfusion injury in H9C2 cells by upregulating heat shock protein 20
  publication-title: Mol Med Rep
– ident: e_1_2_10_5_1
  doi: 10.1016/j.jacc.2015.02.032
– ident: e_1_2_10_4_1
  doi: 10.1016/j.ahj.2015.08.005
SSID ssj0000601600
Score 2.5174093
Snippet Myocardial infarction (MI) is caused by the formation of plaques in the arterial walls, leading to a decrease of blood flow to the heart and myocardium injury...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2966
SubjectTerms Apoptosis
Apoptosis - drug effects
Bioengineering
Blood flow
Cardiomyocytes
Cell death
Cell Hypoxia - drug effects
Cell Hypoxia - physiology
Cell Line
Cell Survival - drug effects
Dehydrogenases
Endoplasmic reticulum
Ferroptosis
Flavonoids - metabolism
Flavonoids - pharmacology
Heart attacks
Hypoxia
Hypoxia - drug therapy
Hypoxia - metabolism
hypoxia/reoxygenation
icariin
Iron
Ischemia
L-Lactate dehydrogenase
lactate dehydrogenase
Lactic acid
Membranes
Myocardial infarction
Myocardial Reperfusion Injury - metabolism
Myocardium
Myocytes, Cardiac - drug effects
NF-E2-Related Factor 2 - drug effects
NF-E2-Related Factor 2 - metabolism
Nrf2/HO‐1 pathway
Oxidative stress
Oxidative Stress - drug effects
Plaques
protective effect
Proteins
Reactive oxygen species
Reactive Oxygen Species - metabolism
Signal transduction
Signal Transduction - drug effects
Software
viability
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZQJSQuiH9SCjISBy7pOrbjJEeKulqQKBcq9Rb5VxsJktXuFpob4gl4Rp6EGSe72hWFXrhFsR3FM2PPN8n4G0Je8dwxxXlIAbzaVPoipKYoXGqVV94jHUj8NPDhTM3O5fuL_GKn1BfmhA30wIPgJoXNhZTSMFEgWzozgWXgY32Re174yuHuCz5vJ5ga9mBkTmMbLh_GJxwinRS5348h_kKGkR03FNn6r4OYf2ZK7iLY6IKm98jdETvSN8M73ye3fPuA3B6qSfYPyY93FgLfpqVNO29Ms17Reb_orhrkgOquerCUqIVf339CHA4adTT45bJbrLtVs6JdoDbmpn7pO9sDAKVfG02XQ6l6GIYdACzSs2Xgk9lHeEpGMflD43l2ioWNv-n-ETmfnn56O0vHEgupzZGBEPRSldKq0tgq5KEy3tgsBCG9DdbZigUpQf6FVzrTFfgyLbzRznjmKmVdEI_JQdu1_imhKojMQPDmA6CcrDBauKCs5K7MlTaqTMjxRuK1HfnHsQzG53pgTuY1qqhGFdVRRQl5vR2wGKg3_t71BFW47Yac2fEGWFI9WlJ9kyUl5GhjAPW4kFc1RIcAcYUsxbXNgjOR4-HiKiEvt82wQvG3i259d4mPUFgPSlXsH30AIgiB3HQJeTKY3HYy8NKwD3MYXewZ495s91vaZh6ZwkH0eHI4IZNotjeJsZ6ensh4dfg_BPqM3OGYARRPbh6Rg_Xy0j8HCLc2L-Jq_Q23_kJG
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3NjtMwELZgERIXxD-BBRmJA5e0ie3YzQEhFm1VkHa5UGlvUezYNNJuUtLubnNDPAHPyJMw46SFastyi2JPFHtmPN8k9jeEvGZJEUnGXAjg1YTCKhdqpYrQSCutRToQ_2ng6FhOpuLTSXLypxxQP4GLnakd1pOaNqeD1bf2HTj8255AdMggiQmR1n0AqZWSN8ktCEsKvfSox_rdsoxkatGa3ueq3FZk8gT-u1Dn1c2Tf4NaH5XG98jdHk7S953-75MbtnpAbncFJtuH5MdHA7lwWdGympW6XC7orJ3XqxJpoepVC8bjFfPr-09IzUHJBXW2aer5sl6UC1o7avx21bO2Ni1gUnpR5rTpqteDGHYA_EiPG8eGk8_wlJjifpAcj7hTrHV8mbePyHR8-OXDJOyrLoQmQVJCUFU6EkaOtEld4lJttYmd48IaZwqTRk6IhAtlZR7nKYS3nFudF9pGRSpN4fhjslfVlX1KqHQ81pDPWQfAJ1Y654WTRrBilMhcy1FABusZz0xPSY6VMU6zjkyZZaiiDFWUeRUF5M1GYN6xcfy76wGqcNMNabT9jbr5mvVemSkDIxFCR1whFX-kXRQDgLMqsUzZtAjI_toAsrVpZpAwAurlYsR3NnMW8QTPG6cBebVpBqfFPzF5ZetzfITEElEyja7pA6iBc6SrC8iTzuQ2g4GXhqWZgbTaMsat0W63VOXMk4fD1ONh4oAMvdn-bxqz8eGB8FfPrh_sc3KH4XYff0xzn-wtm3P7AvDaUr_0fvgbMis9cQ
  priority: 102
  providerName: Scholars Portal
– databaseName: Wiley Online Library Open Access
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NjtMwELZgERIXxD-BBRmJA5dsE9uxkyOLtipILBxYiVtkOzaNBEmVdGFzQzwBz8iTMOO0gcIC4hbVP4o9M_E37sw3hDxmWZVIxnwM4NXGwikfG6Wq2EonnUM6kHA18PJYLk7Ei7fZNpoQc2FGfojpwg0tI3yv0cC16Wc_SEMZuC4xkrkfgEOl5EVyCRNskT6fidfTNUugGwmJKFP_LcFPwma_zLFzNgUK__Nw5-_hkz_D2nAuza-RqxtASZ-OGnCdXHDNDXJ5LDE53CRfnlvwhuuG1s2yNvW6p8th1Z7VSAzVng2gPkE03z5_BeccxFxR77quXa3bvu5p66kNAasfhtYOgErpx1rTbqxfD8OwAyBIetx5Nlu8gllSihEhGpPcKVY7_qSHW-RkfvTm2SLe1F2IbYa0hCCsIhdW5sYWPvOFccam3nPhrLeVLRIvRMaFclKnuoADTnNndGVcUhXSVp7fJntN27i7hErPUwMenfMAfVJlNK-8tIJVeSa1kXlEDrY7XtoNKTnWxnhfjnTKrEQRlSiiMogoIk-mAauRj-PPXQ9RhFM3JNIOP7Tdu3Jjl6WysBIhTMIVkvEnxicpQDinMseUK6qI7G8VoNxYd1-Cywi4l4ucn9vMWcIzzDguIvJoagazxf9idOPaU5xCYpEoWSR_6QO4gXMkrIvInVHlpsXAS8PHmcFotaOMO6vdbWnqZaAPh63HdOKIzILa_msby_nRoQhP9_57xH1yhWEMUMjd3Cd76-7UPQAQtzYPg5l-B1jCPnY
  priority: 102
  providerName: Wiley-Blackwell
Title Icariin inhibits hypoxia/reoxygenation‐induced ferroptosis of cardiomyocytes via regulation of the Nrf2/HO‐1 signaling pathway
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2F2211-5463.13276
https://www.ncbi.nlm.nih.gov/pubmed/34407320
https://www.proquest.com/docview/2591933483
https://www.proquest.com/docview/3203543949
https://www.proquest.com/docview/2562832690
https://www.proquest.com/docview/2718331921
https://pubmed.ncbi.nlm.nih.gov/PMC8564343
https://doaj.org/article/7c53444b03704360bf01893e75e27e9d
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1fb9MwELfYJiReEP_JGJWReOAla2I7TvKEKGpVkFYmxKS9RbFjr5Eg6dIOljfEJ-Az8km4c9KyijFeoii2o9h3dn53Pv-OkJcsKgLJmPUBvGpfmNj6Ko4LX0sjjUE6EOcaOJrJ6Yl4fxqd9g63ZR9WuV4T3UJd1Bp95EPOAh7hMc709eLcx6xRuLvap9DYIXuwBCdgfO2NxrPjjxsvi2MbCYI1p0_AhgwsHh854A_BDkOmkSu_I8fafx3U_Dti8iqSdb-iyT1yt8eQ9E0n9PvklqkekNtdVsn2IfnxToMBXFa0rOalKldLOm8X9WWJXFD1ZQsa46Tx6_tPsMdBsgW1pmnqxapelktaW6pdjOqXttYtAFH6tcxp06Wsh2ZYAUAjnTWWDacf4C0hxSCQHM-1U0xw_C1vH5GTyfjT26nfp1rwdYRMhCCfNBFaJkqnNrKpMkqH1nJhtNWFTgMrRMRFbGQe5ikMdc6NygtlgiKVurD8Mdmt6so8JVRaHiow4owFtBPGKueFlVqwIolkrmTikcP1iGe65yHHdBifs45BmWUoogxFlDkReeTVpsGio-D4d9URinBTDbmz3YO6Ocv6qZjFGnoihAp4jPz7gbJBCKjNxJFhsUkLjxysFSDrJ_QyAysRoC4XCb-2-I92euTFphhmKm6_5JWpL_AVEvNCyTS4oQ5ABc6Ro84jTzqV23QGPhrWYwat4y1l3OrtdklVzh1jOAw9niD2yNCp7f-GMZuMR8Ld7d_c2WfkDsMYH3c284DsrpoL8xxA2koNyA4Tx4N-Pg6cqwOuRyL5DV2GPzM
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELdGJwQviP8EBhgJJF6yprbjNA8IMWjVsq0gtEl7C7Fjr5EgKW3HljfEJ-CT8KH4JNy5SVnFGE97i2LHin3ny--cu98R8pSFWSAZsz6AV-0LE1lfRVHma2mkMUgH4o4GdkdysC_eHoQHa-RnkwuDYZWNTXSGOis1npG3OQt4iGmc8cvJFx-rRuHf1aaExkIttk11DC7b7MXwDcj3GWP93t7rgV9XFfB1iKR78CpxV2jZVTq2oY2VUbpjLRdGW53pOLBChFxERqadNAbznXKj0kyZIIulziyHcS-RdcHBlWmR9a3e6P2H5amOYzcJgoZDKGBtBh6Wj5zzm-D3IbPJqc-fqxJwFrT9O0LzNHJ2n77-dXKtxqz01ULJbpA1U9wklxdVLKtb5PtQg8OdFzQvxrnK5zM6riblSY7cU-VJBRrqpP_r2w_w_0GTMmrNdFpO5uUsn9HSUu1iYj9Xpa4A-NKveUqn5rCuK4YdAKTS0dSy9uAdjNKhGHSSYh49xYLKx2l1m-xfiBDukFZRFuYeodLyjgKn0VhAV51IpTyzUguWdUOZKtn1yGaz4omuec-x_ManZMHYzBIUUYIiSpyIPPJ8-cBkQfnx765bKMJlN-TqdjfK6WFSb_0k0jATIVTAI-T7D5QNOoASTRQaFpk488hGowBJbUBmCXilAK256PIzm__sBo88WTaDZcDfPWlhyiMcQmIdKhkH5_QBaMI5cuJ55O5C5ZaTgZcG-8_g6WhFGVdmu9pS5GPHUA5LjxnLHmk7tf3fMib93pZwV_fPn-xjcmWwt7uT7AxH2w_IVYbxRS4vdIO05tMj8xAA4lw9qnclJR8v2hD8Bq-pfEo
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELdGJxAviP8EBhgJJF6yJnbiNA8IUdaqY1AmxKS9ZbFjr5EgKWnHljfEJ-Dz8HH4JNw5aVnFGE97i2LHin2X8--cu98R8pSFmScYMy6AV-UGOjKujKLMVUILrZEOxB4NvBuL0V7wZj_cXyM_F7kwGFa5sInWUGelwjPyLmceDzGNM-6aNixid2v4cvrFxQpS-Kd1UU6jUZEdXR-D-zZ7sb0Fsn7G2HDw8fXIbSsMuCpEAj54rbgXKNGTKjahiaWWyjeGB1oZlanYM0EQ8iDSIvXTGEx5yrVMM6m9LBYqMxzGvUTWI_CKvA5Z7w_Gux-WJzyW6cTzFnxCHusy8LZc5J_fBB8QWU5ObYW2YsBZMPfvaM3TKNpug8Pr5FqLX-mrRuFukDVd3CSXm4qW9S3yfVuB850XNC8mucznMzqpp-VJjjxU5UkN2mo14de3H3mRgVZl1OiqKqfzcpbPaGmosvGxn-tS1QCC6dc8pZU-bGuMYQcArHRcGdYdvYdRfIoBKCnm1FMsrnyc1rfJ3oUI4Q7pFGWh7xEqDPclOJDaANLyI5nyzAgVsKwXilSKnkM2FyueqJYDHUtxfEoa9maWoIgSFFFiReSQ58sHpg39x7-79lGEy27I221vlNVh0pqBJFIwkyCQHo-Q-9-TxvMBMeoo1CzSceaQjYUCJK0xmSXgoQLM5kGPn9n858twyJNlM1gJ_PWTFro8wiEE1qQSsXdOH4ApnCM_nkPuNiq3nAy8NOwFDJ6OVpRxZbarLUU-sWzlsPSYveyQrlXb_y1jMhz0A3t1__zJPiZXwAAkb7fHOw_IVYahRjZFdIN05tWRfghYcS4ftR8lJQcXbQd-A0-ogH8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Icariin+inhibits+hypoxia%2Freoxygenation%E2%80%90induced+ferroptosis+of+cardiomyocytes+via+regulation+of+the+Nrf2%2FHO%E2%80%901+signaling+pathway&rft.jtitle=FEBS+open+bio&rft.au=Liu%2C+Xiu%E2%80%90Juan&rft.au=Lv%2C+Yan%E2%80%90Fei&rft.au=Cui%2C+Wen%E2%80%90Zhu&rft.au=Li%2C+Yan&rft.date=2021-11-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.eissn=2211-5463&rft.volume=11&rft.issue=11&rft.spage=2966&rft.epage=2976&rft_id=info:doi/10.1002%2F2211-5463.13276&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=1010022211546313276
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2211-5463&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2211-5463&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2211-5463&client=summon